Navigation Links
Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
Date:10/22/2007

ring patients an alternative to oral therapies," said Roy Altman, MD, Professor of Medicine in the Division of Rheumatology and Immunology at UCLA in Los Angeles and Past President of the Osteoarthritis Research Society International. "Voltaren Gel delivers the proven efficacy of diclofenac with significantly less systemic absorption, minimizing the risk of side effects."

The efficacy and safety of Voltaren Gel were studied in more than 900 patients with knee or hand osteoarthritis. The US approval was based on several studies, including the results of two randomized, double-blind, placebo-controlled efficacy studies and a 12-month safety study.

Voltaren Gel was shown to significantly reduce pain in hand and knee osteoarthritis, with pain relief sustained through the end of treatment. After six weeks of treatment in an efficacy study of patients with osteoarthritis of the hand, results showed that pain levels were reduced by nearly half (46%). In a 12-week study in patients with osteoarthritis of the knee, Voltaren Gel showed a 51% reduction in pain.

"Voltaren Gel represents an important clinical milestone - it is the first prescription topical treatment in the US shown to relieve osteoarthritis pain and to clinically prove efficacy in treating both the knees and hands," said Jorge Insuasty, MD, Senior Vice President, Research and Development, Novartis Consumer Health, Inc. "Patients now have the option to effectively treat osteoarthritis pain directly at the source with favorable tolerability."

Approximately 21 million people in the US have osteoarthritis,(1) and the aging population in the US means 72 million more will be at risk for developing the condition by 2030.(2) Osteoarthritis is a chronic, painful condition that often leads to working limitations and reduced overall health.(3)

About osteoarthritis

Osteoarthritis is a chronic condition characterized by the breakdown of cartilage in the joint. Cartilage cushions the ends
'/>"/>

SOURCE Novartis
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Medical Center clinical researchers have launched an innovative ... evaluate the ability of a patient,s own stem ... peripheral arterial disease (PAD). , Led by ... University Hospitals Case Medical Center,s Harrington Heart & ... Western Reserve University School of Medicine, the clinical ...
(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
(Date:6/18/2013)... 2013 myCNAjobs announces the addition of ... articles, and tips to the Caregiver Resources Center. , ... the 10,000+ retiring baby boomers each day, the need ... job resources has never been greater. myCNAjobs, ... community, recently launched the first-ever free resource center for ...
(Date:6/18/2013)... 18, 2013 A new $119 million ... burgeoning aquaculture industry is redefining the way consumers get ... most acclaimed personal culinary chefs on the Emerald Coast ... of sustainable seafood and the promising industry of aquaculture. ... days. Many consumers strive to fully partake in the ...
(Date:6/18/2013)... Pomona, Calif. (PRWEB) June 18, 2013 ... associate professor of Family Medicine for the College of ... of Health Sciences has been elected president of the ... Gov. Edmund G. Brown Jr. appointed Connett, a 1984 ... , OMBC members recently elected Connett to the position ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:New $119 Million Industry Swimming Up the East Coast 2
... likely to be infected with Hepatitis C virus compared ... get treatment for their liver disease because current antiviral ... this epidemiological background, the article by Schaefer and colleagues, ... important study in the field, write Sanjeev Arora and ...
... 72 posters, lectures, and mini-symposia given by University of Pennsylvania ... new research findings on the molecular workings of several types ... American Society of Cell Biology takes place on December 1-5, ... Huntington,s Disease: A new role has been discovered for ...
... 3 inVentiv Health, Inc.,(Nasdaq: VTIV ) today ... be held Tuesday, December 11th, 2007 in New York ... 9:00 a.m. as announced earlier, and,will conclude at noon, ... business overview, presentations by the,leaders of each of the ...
... N.C., Dec. 3 LipoScience, Inc. is pleased to,announce ... of Directors., Mr. Landon has over 30 years ... retiring from active management, Mr. Landon,was Vice President & ... full functional responsibility for all of DuPont,s Medical,Products businesses, ...
... research from a lab at Florida State University reveals ... it, resisting temptations to misbehave, our fuel tank is ... , Florida State psychologist Roy F. Baumeister and his ... M. Tice, Florida State, showed this with an experiment ...
... An inhaled immune system stimulant protects mice against ... and fungal infections of the lungs, a research ... Texas M. D. Anderson Cancer Center reports at ... have implications for protecting immuno-compromised patients against infection ...
Cached Medicine News:Health News:Treating patients with psychiatric disorders for hepatitis C 2Health News:Penn talks at ASCB touch on cancer, neurodegenerative diseases, and MD 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 3Health News:Got sugar? Glucose affects our ability to resist temptation 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 2Health News:Aerosol launches immune response in lungs to wipe out lethal infections 3
(Date:6/18/2013)... 2013 Royal Philips (NYSE: PHG, ... Performance Leader in Imaging Equipment in the 2013 Best ... also received Best in KLAS and Best in Category ... 128 Computed Tomography (CT), Ingenia 1.5T and 3.0T ... The annual Best in KLAS Awards: Medical Imaging & ...
(Date:6/18/2013)... June 18, 2013  Specialty Coating Systems ... in Parylene coating technologies: SCS microRESIST™ Antimicrobial ... of Parylene with antimicrobial properties to effectively ... components. (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ... increase and continue to pose a challenge ...
(Date:6/18/2013)... -- Decision Resources, one of the world,s leading research and ... the past 12 months, 25 percent of surveyed physicians from ... , Italy , Spain ... have been required to change the antiretroviral (ARV) prescription for ... costs. Additionally, more than 40 percent of respondents report that ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
... Nov. 7, 2011 Zimmer Holdings, Inc. ... agreed to sell $550 million of senior notes in an ... Smith Incorporated, BNP Paribas Securities Corp. and RBS Securities ... LLC, Credit Suisse Securities (USA) LLC, Citigroup Global Markets ...
... 7, 2011 ERT (Nasdaq: ERT ), ... President and CEO is scheduled to present at the ... on Nov. 15, 2011 in Las Vegas. ... Company,s corporate website at http://www.ert.com . The webcast ...
Cached Medicine Technology:Zimmer Holdings, Inc. Agrees to Sell $550 Million of Senior Notes 2ERT to Present at the Citi 2011 Global Health Care Conference on November 15, 2011 2
... ,Offers an average 5:1 increase in usage time ... of a standard cannula. , ,The combination ... ambulatory oxygen patients a superior alternative to liquid ... warranty. , ,NOTE: ...
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
... Ultra Micro Shafts For Insertion Through A ... Light-Weight ... Shafts For A More Comfortable Approach., ,Recessed ... Cap Supplied For Protection Of Jaws During ...
Medicine Products: